P
Pyxis Oncology, Inc. Common StockPYXS
Pyxis Oncology, Inc. is a clinical-stage biopharmaceutical company developing therapeutics for difficult-to-treat cancers. The Company's lead candidate, micvotabart pelidotin (MICVO), is a first-in-concept antibody drug conjugate (ADC) that targets extradomain-B of fibronectin (EDB+FN), a non-cellular structural component of the tumor extracellular matrix.
US StocksHealthcareSmall CapGrowth Stocks
PYXS 가격 추세
Pyxis Oncology, Inc. Common Stock · TradingView 전체 차트
NASDAQ:PYXS